National Laboratory Pathfinder - Vaccine - Salmonella (NLP-Vaccine-Salmonella) - 05.13.15

Overview | Description | Applications | Operations | Results | Publications | Imagery

ISS Science for Everyone

Science Objectives for Everyone
National Laboratory Pathfinder - Vaccine - Salmonella (NLP-Vaccine-Salmonella) investigation uses microgravity to examine Salmonella, a pathogenic (disease-causing) organism, to develop a potential vaccine for the prevention of infection on Earth and in microgravity.
Science Results for Everyone
Information Pending

The following content was provided by Timothy G. Hammond, M.B.B.S., and is maintained in a database by the ISS Program Science Office.
Experiment Details

OpNom:

Principal Investigator(s)
Timothy G. Hammond, M.B.B.S., Durham Veterans' Affairs Medical Center, Durham, NC, United States

Co-Investigator(s)/Collaborator(s)
Information Pending

Developer(s)
BioServe Space Technologies, University of Colorado, Boulder, CO, United States

Sponsoring Space Agency
National Aeronautics and Space Administration (NASA)

Sponsoring Organization
National Laboratory (NL)

Research Benefits
Information Pending

ISS Expedition Duration
October 2007 - September 2011

Expeditions Assigned
16,17,18,19/20,23/24,27/28

Previous ISS Missions
The NLP-Vaccine series of investigations began on STS-123/1JA during ISS Expedition 16.

^ back to top

Experiment Description

Research Overview

  • Salmonella strains of bacteria are the most common cause of food poisoning world-wide, and a major cause of childhood death worldwide. In the United States, illnesses caused by Salmonella cost billions of dollars annually. There is currently no vaccine available for the common forms of salmonella gastroenteritis.


  • National Laboratory Pathfinder - Vaccine - Salmonella (NLP-Vaccine-Salmonella) uses a unique and simple model of infection. The Salmonella is grown in space under conditions known to effect bacterial potency. The strains identified as the least potent following microgravity exposure are selected as candidates for use in vaccine development on Earth.


  • Salmonella and Caenorhabditis elegans worms are launched separated, then serially mixed, grown and fixed in flight. Once the experiment is completed on orbit and returned to Earth, analysis of virulence (infection potential) is completed by the investigator.

Description
The 2005 NASA Authorization Act designated a portion of the International Space Station (ISS) as a National Laboratory. To fulfill that mandate, NASA is providing an opportunity for non-governmental entities to conduct research and development and potentially industrial processing on board the ISS. These opportunities aboard the ISS are considered National Lab Pathfinder (NLP) missions. These NLP missions launch to the ISS on each available shuttle mission.

National Laboratory Pathfinder - Vaccine - Salmonella (NLP-Vaccine-Salmonella) takes advantage of knowledge gained in previous space flight studies of microorganisms. This investigation grows several species of Salmonella, including Salmonella enteriditis, Salmonella enterica and Salmonella typhirium, in microgravity to affect the virulence (infection potential). Salmonella is a rod-shaped, flagellated, aerobic, gram-negative bacterium. Salmonella strains are the most common cause of food poisoning world-wide, and a major cause of childhood death worldwide. In the United States, illnesses caused by Salmonella cost billions of dollars annually. There is currently no vaccine available for the most common forms of salmonella gastroenteritis caused by these pathogens.
Each flight opportunity of this investigation provides additional insight about the bacteria and the changes that are occurring as they grow in space. The knowledge is applied to streamline and accelerate the development of vaccines and therapeutics on Earth.

The Salmonella microbes and the Caenorhabditis elegans worms are launched separated and serially mixed, grown and fixed in flight. Once the experiment is completed on orbit and returned to Earth, analysis of virulence is completed by the investigator.

NLP-Vaccine-Salmonella flies on the Space Shuttle to the ISS as NLP-Vaccine-1A, NLP-Vaccine-1B, NLP-Vaccine-2, NLP-Vaccine-5 and NLP-Vaccine-9.

^ back to top

Applications

Space Applications
Results from this experiment may help scientists more clearly understand measures that should be taken to reduce the risk of infection and contraction of disease while in space.

Earth Applications
There is currently no vaccine available for the strains of organisms being examined by the NLP-Vaccine series of investigations. This research may help develop vaccines against life threatening organisms.

^ back to top

Operations

Operational Requirements
This payload is conducted under ambient temperature conditions and does not require image or data download.

Operational Protocols
The research is contained in the Fluid Processing Apparatus (FPA). In order to activate the samples, the crew turns a hand crank that has been inserted onto the top of the GAP which contains the FPAs. Once the samples are activated for a predetermined length of time, the crew again turns the hand crank on top of the GAPs to terminate the experiment. The terminated samples are returned to Earth via the shuttle.

^ back to top

Results/More Information

^ back to top

Results Publications

    Hammond TG, Stodieck LS, Birdsall HH, Becker JL, Koenig PM, Hammond JS, Gunter MA, Allen PL.  Effects of microgravity on the virulence of Salmonella toward Caenorhabditis elegans. New Space. 2013 September; 1(3): 123-131. DOI: 10.1089/space.2013.0011.

^ back to top

Ground Based Results Publications

^ back to top

ISS Patents

^ back to top

Related Publications

^ back to top

Related Websites
Astrogenetix
BioServe Space Technologies
Media Advisory - NASA Studies Microbes on Space Shuttle Flight
Payoffs from ISS Research
VA Research Project on NASA Space Shuttle

^ back to top


Imagery

image NASA Image: S126E007561 - STS-126/ULF2 Mission Specialist Shane Kimbrough works with the Group Activation Pack (GAP) for a National Lab Pathfinder-Vaccine investigation on the orbiter Endeavour.
+ View Larger Image


image Salmonella bacteria that have been cultured in a tetrathionate-enrichment broth, and stained using the direct fluorescent-antibody technique. Image courtesy of the Centers for Disease Control and Prevention, Image ID - 6648.
+ View Larger Image


image Color-enhanced scanning electron micrograph showing Salmonella typhimurium (red) invading cultured human cells. Image courtesy of Rocky Mountain Laboratories, National Institute of Allergy and infectious Diseases.
+ View Larger Image


image Salmonella, isolated from infected macrophages, mildly color-enhanced. Image courtesy of Pacific Northwest National Laboratory.
+ View Larger Image


image
NASA Image: S134E006436 - NASA astronauts Greg Chamitoff (left), mission specialist, and Mark Kelly, mission commander, are unpacking canisters of the Group Activation Pack.

+ View Larger Image